Short Bowel Syndrome
Pipeline by Development Stage
Drug Modality Breakdown
On Market (1)
Approved therapies currently available
Competitive Landscape
17 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Showing 15 of 21 trials with date data
Clinical Trials (21)
Total enrollment: 2,473 patients across 21 trials
Characterization of the Long-term Safety, Efficacy, and Pharmacodynamics Revestive® in the Management of Short Bowel Syndrome Pediatric Patients
Evaluate the Efficacy and Safety Growth Hormone, Glutamine and Diet in Patients With Short Bowel Syndrome (SBS)
Efficacy and Safety of PJ009 in Patients With Short Bowel Syndrome Requiring Parenteral Nutrition
Study of Teduglutide in Japanese Participants With Short Bowel Syndrome
A Pharmacokinetic, Safety, and Pharmacodynamic Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome
Safety and Efficacy Study in Infant With SBS
Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects
Use of Pancreatic Enzymes in Short Bowel Syndrome
Can SMOFlipid®, A Composite Parenteral Nutrition Lipid Emulsion, Prevent Progression Of Parenteral Nutrition Associated Liver Disease In Infants?
A Study of PJ009 in Healthy Adult Volunteers
Absorption of Antibiotics With High Oral Bioavailability in Short-bowel Syndrome
Study of NST-6179 in Healthy Subjects
Safety and Immunogenicity of Rotavirus Vaccine (RotaTeq(R)) in Infants With Short Bowel Syndrome
A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients With Short Bowel Syndrome
A 90 Day Observational Study as an Extension to the Phase 3,Open Labeled Exploratory Study of RELiZORB
Pediatric Teduglutide Registry
Quality of Life in Patients With Short Bowel Syndrome Treated Without and With Teduglutide - a Prospective Nested Matched Pair Analysis
A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB
Registry for Participants With Short Bowel Syndrome
Infant & Toddler Short Gut Feeding Outcomes Study
Fiber Use in Pediatric Short Bowel Syndrome
Related Jobs
Senior Manager, FP&A
Head of Drug Product Development
Senior Director, Investor Relations and Corporate Communications
Clinical Operations Lead, Development Operations
Director, Global Regulatory Affairs (GRA) - CMC
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.